Analysis of regional differences in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC)

被引：1

作者：

Tannir, N. ^{[1
]}

Powles, T. ^{[2
]}

Motzer, R. J. ^{[3
]}

Rolland, F. ^{[4
]}

Gravis, G. ^{[5
]}

Staehler, M. ^{[6
]}

Rink, M. ^{[7
]}

Retz, M. ^{[8
]}

Csoszi, T. ^{[9
]}

McCaffrey, J. ^{[10
]}

De Giorgi, U. ^{[11
]}

Caserta, C. ^{[12
]}

Cheporov, S. ^{[13
]}

Esteban Gonzalez, E. ^{[14
]}

Duran, I. ^{[15
]}

Larkin, J. G. ^{[16
]}

Berg, W. ^{[17
]}

Clary, D. ^{[17
]}

Escudier, B. ^{[18
]}

Choueiri, T. K. ^{[19
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Genitourinary Med Oncol, Houston, TX 77030 USA

[2] Queen Mary Univ London, Barts Canc Inst, Expt Canc Med, London, England

[3] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[4] ICO Inst Cancerol Ouest Rene Gauducheau, Med Oncol, St Herblain, France

[5] Inst Paoli Calmettes, Med Outpatient, Urol, Marseille, France

[6] Maximilians Univ Munchen, Klinikum Ludwig, Urol, Munich, Germany

[7] Univ Med Ctr Hamburg Eppendorf, Urol, Hamburg, Germany

[8] Klinikum Rechts Isar Tech, Urol, Munich, Germany

[9] Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz R, Med Oncol & Hematol, Szolnok, Hungary

[10] Mater Private Hosp, Med Oncol, Oncol, Dublin, Ireland

[11] Ist Sci Romagnolo Studio & Cura Tumori, Med Oncol, Meldola, Italy

[12] Azienda Osped Sta Maria, Oncol, Terni, Italy

[13] Reg Clin Oncol Hosp, Clin Oncol, Yaroslavl, Russia

[14] Clinica, Oncol, Edificio Consultas Externas, Oviedo, Spain

[15] Hosp Univ Virgen del Rocio, Med Oncol, Seville, Spain

[16] Royal Marsden Hosp NHS Fdn Trust, Med Oncol, London, England

[17] Exelixis Inc, Med Affairs, San Francisco, CA USA

[18] Inst Gustave Roussy, Immunotherapy & Innovat Therapy Unit, Villejuif, France

[19] Brigham & Womens Hosp, Dana Farber Canc Inst, Genitourinary Oncol, 75 Francis St, Boston, MA 02115 USA

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw373.45

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

818P

引用

页数：1

共 50 条

[21] Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
Donskov, Frede
Motzer, Robert J.
Voog, Eric
Hovey, Elizabeth
Gruellich, Carsten
Nott, Louise M.
Cuff, Katharine
Gil, Thierry
Jensen, Niels Viggo
Chevreau, Christine
Negrier, Sylvie
Depenbusch, Reinhard
Bergmann, Lothar
Cornelio, Izzy
Champsaur, Anne
Escudier, Bernard
Pal, Sumanta
Powles, Thomas
Choueiri, Toni K.
EUROPEAN JOURNAL OF CANCER, 2020, 126 : 1 - 10
[22] Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (rcc)
Powles, T.
Motzer, R. J.
George, D. J.
Jonasch, E.
Pal, S.
Tannir, N. M.
Signoretti, S.
Mai, T. H.
Scheffold, C.
Wang, E.
Aftab, D. T.
Escudier, B.
Choueiri, T. K.
ANNALS OF ONCOLOGY, 2017, 28
[23] Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (RCC)
Gruellich, C.
Powles, T.
Motzer, R. J.
George, D. J.
Jonasch, E.
Pal, S. K.
Tannir, N. M.
Signoretti, S.
Mai, T. H.
Scheffold, C.
Wang, E.
Aftab, D. T.
Escudier, B. J.
Choueiri, T. K.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 201 - 201
[24] Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma
Tannir, Nizar M.
Powles, Thomas
Escudier, Bernard
Donskov, Frede
Gruenwald, Viktor
Sternberg, Cora N.
Schmidinger, Manuela
Schoeffski, Patrick
Szczylik, Cezary
Peltolta, Katriina
Nosov, Dmitry
Melichar, Bohuslav
Clary, Douglas
Scheffold, Christian
Motzer, Robert J.
Choueiri, Toni K.
KIDNEY CANCER, 2020, 4 (01) : 29 - 39
[25] Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study
Bracarda, S.
Choueiri, T. K.
Powles, T.
Motzer, R. J.
Olencki, T.
Frontera, O. A.
Oudard, S.
Rolland, F.
Tomczak, P.
Castellano, D.
Appleman, L.
Drabkin, H.
Vaena, D.
Milwee, S.
Youkstetter, J.
Escudier, B.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S196 - S196
[26] Phase 3 randomized study of cabozantinib (XL184) versus everolimus in subjects with dear cell renal cell carcinoma (METEOR)
Choueiri, Toni K.
Escudier, Bernard J.
Les, Thomas Pow
Cella, David
Ru, Qinhua C.
Scheffold, Christian
Motzer, Robert J.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[27] Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, T. K.
Escudier, B.
Powles, T.
Mainwaring, P. N.
Rini, B. I.
Donskov, F.
Hammers, H.
Hutson, T. E.
Lee, J-L
Peltola, K.
Roth, B. J.
Bjarnason, G. A.
Geczi, L.
Keam, B.
Maroto, P.
Heng, D. Y. C.
Schmidinger, M.
Kantoff, P. W.
Borgman-Hagey, A.
Hessel, C.
Scheffold, C.
Schwab, G. M.
Tannir, N. M.
Motzer, R. J.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19): : 1814 - 1823
[28] Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR)
Schmidinger, M.
Motzer, R. J.
Powles, T.
Escudier, B.
Tannir, N. M.
Mainwaring, P. N.
Rini, B. I.
Hammers, H. J.
Donscov, F.
Roth, B.
Peltola, K.
Lee, J. L.
Heng, D. Y. C.
Aftab, D. T.
Hessel, C.
Scheffold, C.
Schwab, G.
Pal, S.
Hutson, T. E.
Choueiri, T. K.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S187 - S188
[29] Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K.
Escudier, Bernard
Powles, Thomas
Tannir, Nizar M.
Mainwaring, Paul N.
Rini, Brian I.
Hammers, Hans J.
Donskov, Frede
Roth, Bruce J.
Peltola, Katriina
Lee, Jae Lyun
Heng, Daniel Y. C.
Schmidinger, Manuela
Agarwal, Neeraj
Sternberg, Cora N.
McDermott, David F.
Aftab, Dana T.
Hessel, Colin
Old, Christian Scheff
Schwab, Gisela
Hutson, Thomas E.
Pal, Sumanta
Motzer, Robert J.
LANCET ONCOLOGY, 2016, 17 (07): : 917 - 927
[30] Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?
Ciccarese, Chiara
Massari, Francesco
Tortora, Giampaolo
EUROPEAN UROLOGY, 2016, 69 (05) : 969 - 970

← 1 2 3 4 5 →